These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exogenous surfactant in neonatal respiratory distress syndrome. Cashore WJ R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814 [No Abstract] [Full Text] [Related]
3. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G; Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176 [TBL] [Abstract][Full Text] [Related]
4. Impact of surfactant replacement therapy on the nursery. Nightengale B Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368 [No Abstract] [Full Text] [Related]
5. [Nitric oxide in the acute care of newborns and premature infants]. Aikio O; Hallman M Duodecim; 2004; 120(15):1853-8. PubMed ID: 15508758 [No Abstract] [Full Text] [Related]
6. Surfactant status in preterm neonates recovering from respiratory distress syndrome. Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992 [TBL] [Abstract][Full Text] [Related]
7. Neonatal and infant problems of low birth weight. Rosenberg AA Curr Opin Obstet Gynecol; 1991 Feb; 3(1):8-14. PubMed ID: 1878501 [TBL] [Abstract][Full Text] [Related]
8. Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond. Sürmeli-Onay O; Korkmaz A; Yiğit S; Yurdakök M Turk J Pediatr; 2012; 54(3):239-46. PubMed ID: 23094533 [TBL] [Abstract][Full Text] [Related]
13. Innovations in cardiopulmonary care of the low-birth-weight infant. Cusson RM NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(1):62-74. PubMed ID: 1562447 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades? Mugford M Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971 [TBL] [Abstract][Full Text] [Related]
15. Use of natural surfactants to prevent and treat respiratory distress syndrome. Spafford PS; Kendig JW; Maniscalco WM Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443 [No Abstract] [Full Text] [Related]
16. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome. Ghaemi S; Mohamadymasodi M; Kelishadi R Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953 [TBL] [Abstract][Full Text] [Related]
17. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease]. Lubetzky R; Dolberg S Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346 [No Abstract] [Full Text] [Related]
18. A surviving baby born 24 weeks of gestational age and 490g weight without mechanic ventilation and surfactant replacement. Akcam M Saudi Med J; 2004 Oct; 25(10):1504-5. PubMed ID: 15494837 [No Abstract] [Full Text] [Related]
19. Use of surfactant for respiratory distress syndrome. Mallamo K Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888 [No Abstract] [Full Text] [Related]